This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nishi, H. Articles by Sasazuki, T. Search for Related Content PubMed PubMed Citation Articles by Nishi, H. Articles by Sasazuki, T.

(Circulation. 1995;91:2911-2915.)
© 1995 American Heart Association, Inc.

Articles

A Myosin Missense Mutation, Not A Null Allele, Causes Familial Hypertrophic Cardiomyopathy

Hirofumi Nishi, MD; Akinori Kimura, MD; Haruhito Harada, MD; Yoshinori Koga, MD; Kyo Adachi, MD; Kohmei Matsuyama, MD; Takeshi Koyanagi, MD; Seikoh Yasunaga, MD; Tsutomu Imaizumi, MD; Hironori Toshima, MD; Takehiko Sasazuki, MD

From the Third Department of Internal Medicine, Kurume University School of Medicine, Kurume (H.N., H.H., Y.K., K.A., K.M., T.K., T.I., H.T.), and the Department of Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka (H.N., A.K., H.H., T.K., S.Y., T.S.), Japan.

Correspondence to A. Kimura, MD, Department of Tissue Physiology, Division of Adult Diseases, Medical Research Institute, Tokyo Medical and Dental University, Kandasurugadai 2-3-10, Chiyoda-ku, Tokyo 101, Japan.

Background Hypertrophic cardiomyopathy (HCM) is characterized by myocardial hypertrophy of unknown etiology. Missense mutations of the cardiac ß–myosin-heavy-chain (ß-MHC) gene that may be responsible for cardiac hypertrophy have been detected in patients with HCM. On the other hand, gross structural abnormalities in the cardiac ß-MHC gene, ie, an /ß hybrid gene and partial deletion of the gene, have also been reported. The direct correlation between gross abnormalities and development of HCM is not well understood.

Methods and Results We analyzed the structure of the cardiac ß-MHC gene from patients with HCM by using polymerase chain reaction–DNA conformation polymorphism analysis and found two sequence variations in exons 3 and 22 in one patient. These sequence variations at codon 54 (exon 3; nonsense mutation) and codon 870 (exon 22; Arg-to-His mutation) were identified by direct sequencing and dot-blot hybridization with allele-specific oligonucleotide probes. Relatives of this patient were examined for the mutations. It was revealed that the missense mutation was inherited from the affected father and the nonsense mutation from the unaffected grandmother through the unaffected mother. In addition, the missense mutation was also found in seven other patients from two other unrelated multiplex HCM families.

Conclusions The Arg⁸⁷⁰His mutation was suggested to cause HCM. In contrast, the gene with the nonsense mutation would encode for a cardiac ß-MHC protein of only 53 amino acid residues, which may be too short to be incorporated into the thick filament assembly of cardiac myosin chains and showed no dominant phenotype of heart disease. This is the first report of a nonsense mutation in the human cardiac ß-MHC gene.

Key Words: hypertrophy • cardiomyopathy • gene • myosin

This article has been cited by other articles:

				M. Kelly and C. Semsarian Multiple Mutations in Genetic Cardiovascular Disease: A Marker of Disease Severity? Circ Cardiovasc Genet, April 1, 2009; 2(2): 182 - 190. [Full Text] [PDF]

				Y. M. Hoedemaekers, K. Caliskan, D. Majoor-Krakauer, I. van de Laar, M. Michels, M. Witsenburg, F. J. ten Cate, M. L. Simoons, and D. Dooijes Cardiac {beta}-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies Eur. Heart J., November 2, 2007; 28(22): 2732 - 2737. [Abstract] [Full Text] [PDF]

				T. Konno, M. Shimizu, H. Ino, M. Yamaguchi, H. Terai, K. Uchiyama, K. Oe, T. Mabuchi, T. Kaneda, and H. Mabuchi Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis Eur. Heart J., February 1, 2004; 25(3): 246 - 251. [Abstract] [Full Text] [PDF]

				E. Blair, S. J Price, C. J Baty, I. Östman-Smith, and H. Watkins Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy J. Med. Genet., June 1, 2001; 38(6): 385 - 388. [Full Text]

				A Muraishi, H Kai, K Adachi, H Nishi, and T Imaizumi Malalignment of the sarcomeric filaments in hypertrophic cardiomyopathy with cardiac myosin heavy chain gene mutation Heart, November 1, 1999; 82(5): 625 - 629. [Abstract] [Full Text]

				C. S. Redwood, J. C. Moolman-Smook, and H. Watkins Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy Cardiovasc Res, October 1, 1999; 44(1): 20 - 36. [Abstract] [Full Text] [PDF]

				P. Richard, R. Isnard, L. Carrier, O. Dubourg, Y. Donatien, B. Mathieu, G. Bonne, F. Gary, P. Charron, A. Hagege, et al. Double heterozygosity for mutations in the beta -myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy J. Med. Genet., July 1, 1999; 36(7): 542 - 545. [Abstract] [Full Text]

				G. Bonne, L. Carrier, P. Richard, B. Hainque, and K. Schwartz Familial Hypertrophic Cardiomyopathy : From Mutations to Functional Defects Circ. Res., September 21, 1998; 83(6): 580 - 593. [Abstract] [Full Text] [PDF]

				H. Kai, A. Muraishi, Y. Sugiu, H. Nishi, Y. Seki, F. Kuwahara, A. Kimura, H. Kato, and T. Imaizumi Expression of Proto-oncogenes and Gene Mutation of Sarcomeric Proteins in Patients With Hypertrophic Cardiomyopathy Circ. Res., September 21, 1998; 83(6): 594 - 601. [Abstract] [Full Text] [PDF]

				K. Schwartz Familial Hypertrophic Cardiomyopathy : Nonsense Versus Missense Mutations Circulation, June 15, 1995; 91(12): 2865 - 2867. [Full Text]